Close Menu

NEW YORK – Life science instrument manufacturer Atonarp said today it has completed a $33 million Series C round.

The Tokyo-based firm said it will use the funding to support prototyping and commercialization of its mass spectrometry and optical spectroscopy instruments, which are targeted at industrial and diagnostic applications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.